Chronic Kidney Disease (CKD) constitutes a major global medical burden, marked by the gradual deterioration of renal function, which results in the impaired clearance of metabolic waste and disturbances in systemic fluid homeostasis. Owing to its substantial contribution to worldwide morbidity and mortality, the development of reliable and efficient diagnostic approaches is critically important to facilitate early detection and prompt clinical management. This study presents a deep convolutional neural network (CNN) for early CKD detection from CT kidney images, complemented by class balancing using Synthetic Minority Over-sampling Technique (SMOTE) and interpretability via Gradient-weighted Class Activation Mapping (Grad-CAM). The model was trained and evaluated on the CT KIDNEY DATASET, which contains 12,446 CT images, including 3,709 cyst, 5,077 normal, 1,377 stone, and 2,283 tumor cases. The proposed deep CNN achieved a remarkable classification performance, attaining 100% accuracy in the early detection of chronic kidney disease (CKD). This significant advancement demonstrates strong potential for addressing critical clinical diagnostic challenges and enhancing early medical intervention strategies.

Patients with acute kidney injury (AKI) are at high risk of developing chronic kidney disease (CKD), but identifying those at greatest risk remains challenging. We used electronic health record (EHR) data to dynamically track AKI patients' clinical evolution and characterize AKI-to-CKD progression. Post-AKI clinical states were identified by clustering patient vectors derived from longitudinal medical codes and creatinine measurements. Transition probabilities between states and progression to CKD were estimated using multi-state modeling. After identifying common post-AKI trajectories, CKD risk factors in AKI subpopulations were identified through survival analysis. Of 20,699 patients with AKI at admission, 3,491 (17%) developed CKD. We identified fifteen distinct post-AKI states, each with different probabilities of CKD development. Most patients (75%, n=15,607) remained in a single state or made only one transition during the study period. Both established (e.g., AKI severity, diabetes, hypertension, heart failure, liver disease) and novel CKD risk factors, with their impact varying across these clinical states. This study demonstrates a data-driven approach for identifying high-risk AKI patients, supporting the development of decision-support tools for early CKD detection and intervention.

Chronic Kidney Disease (CKD) affects nearly 10\% of the global population and often progresses to end-stage renal failure. Accurate prognosis prediction is vital for timely interventions and resource optimization. We present a transformer-based framework for predicting CKD progression using multi-modal electronic health records (EHR) from the Seoul National University Hospital OMOP Common Data Model. Our approach (\textbf{ProQ-BERT}) integrates demographic, clinical, and laboratory data, employing quantization-based tokenization for continuous lab values and attention mechanisms for interpretability. The model was pretrained with masked language modeling and fine-tuned for binary classification tasks predicting progression from stage 3a to stage 5 across varying follow-up and assessment periods. Evaluated on a cohort of 91,816 patients, our model consistently outperformed CEHR-BERT, achieving ROC-AUC up to 0.995 and PR-AUC up to 0.989 for short-term prediction. These results highlight the effectiveness of transformer architectures and temporal design choices in clinical prognosis modeling, offering a promising direction for personalized CKD care.

Kidneys are the filter of the human body. About 10% of the global population is thought to be affected by Chronic Kidney Disease (CKD), which causes kidney function to decline. To protect in danger patients from additional kidney damage, effective risk evaluation of CKD and appropriate CKD monitoring are crucial. Due to quick and precise detection capabilities, Machine Learning models can help practitioners accomplish this goal efficiently; therefore, an enormous number of diagnosis systems and processes in the healthcare sector nowadays are relying on machine learning due to its disease prediction capability. In this study, we designed and suggested disease predictive computer-aided designs for the diagnosis of CKD. The dataset for CKD is attained from the repository of machine learning of UCL, with a few missing values; those are filled in using "mean-mode" and "Random sampling method" strategies. After successfully achieving the missing data, eight ML techniques (Random Forest, SVM, Naive Bayes, Logistic Regression, KNN, XGBoost, Decision Tree, and AdaBoost) were used to establish models, and the performance evaluation comparisons among the result accuracies are measured by the techniques to find the machine learning models with the highest accuracy. Among them, Random Forest as well as Logistic Regression showed an outstanding 99% accuracy, followed by the Ada Boost, XGBoost, Naive Bayes, Decision Tree, and SVM, whereas the KNN classifier model stands last with an accuracy of 73%.

Background: Hypertensive kidney disease (HKD) patients in intensive care units (ICUs) face high short-term mortality, but tailored risk prediction tools are lacking. Early identification of high-risk individuals is crucial for clinical decision-making. Methods: We developed a machine learning framework to predict 30-day in-hospital mortality among ICU patients with HKD using early clinical data from the MIMIC-IV v2.2 database. A cohort of 1,366 adults was curated with strict criteria, excluding malignancy cases. Eighteen clinical features-including vital signs, labs, comorbidities, and therapies-were selected via random forest importance and mutual information filtering. Several models were trained and compared with stratified five-fold cross-validation; CatBoost demonstrated the best performance. Results: CatBoost achieved an AUROC of 0.88 on the independent test set, with sensitivity of 0.811 and specificity of 0.798. SHAP values and Accumulated Local Effects (ALE) plots showed the model relied on meaningful predictors such as altered consciousness, vasopressor use, and coagulation status. Additionally, the DREAM algorithm was integrated to estimate patient-specific posterior risk distributions, allowing clinicians to assess both predicted mortality and its uncertainty. Conclusions: We present an interpretable machine learning pipeline for early, real-time risk assessment in ICU patients with HKD. By combining high predictive performance with uncertainty quantification, our model supports individualized triage and transparent clinical decisions. This approach shows promise for clinical deployment and merits external validation in broader critical care populations.

Despite the outstanding performance of deep learning models in clinical prediction tasks, explainability remains a significant challenge. Inspired by transformer architectures, we introduce the Temporal-Feature Cross Attention Mechanism (TFCAM), a novel deep learning framework designed to capture dynamic interactions among clinical features across time, enhancing both predictive accuracy and interpretability. In an experiment with 1,422 patients with Chronic Kidney Disease, predicting progression to End-Stage Renal Disease, TFCAM outperformed LSTM and RETAIN baselines, achieving an AUROC of 0.95 and an F1-score of 0.69. Beyond performance gains, TFCAM provides multi-level explainability by identifying critical temporal periods, ranking feature importance, and quantifying how features influence each other across time before affecting predictions. Our approach addresses the "black box" limitations of deep learning in healthcare, offering clinicians transparent insights into disease progression mechanisms while maintaining state-of-the-art predictive performance.

Modeling disease progression through multiple stages is critical for clinical decision-making for chronic diseases, e.g., cancer, diabetes, chronic kidney diseases, and so on. Existing approaches often model the disease progression as a uniform trajectory pattern at the population level. However, chronic diseases are highly heterogeneous and often have multiple progression patterns depending on a patient's individual genetics and environmental effects due to lifestyles. We propose a personalized disease progression model to jointly learn the heterogeneous progression patterns and groups of genetic profiles. In particular, an end-to-end pipeline is designed to simultaneously infer the characteristics of patients from genetic markers using a variational autoencoder and how it drives the disease progressions using an RNN-based state-space model based on clinical observations. Our proposed model shows improvement on real-world and synthetic clinical data.

Background: Chronic kidney disease (CKD), a progressive disease with high morbidity and mortality, has become a significant global public health problem. At present, most of the models used for predicting the progression of CKD are static models. We aim to develop a dynamic kidney failure prediction model based on deep learning (KFDeep) for CKD patients, utilizing all available data on common clinical indicators from real-world Electronic Health Records (EHRs) to provide real-time predictions. Findings: A retrospective cohort of 4,587 patients from EHRs of Yinzhou, China, is used as the development dataset (2,752 patients for training, 917 patients for validation) and internal validation dataset (917 patients), while a prospective cohort of 934 patients from the Peking University First Hospital CKD cohort (PKUFH cohort) is used as the external validation dataset. The AUROC of the KFDeep model reaches 0.946 (95\% CI: 0.922-0.970) on the internal validation dataset and 0.805 (95\% CI: 0.763-0.847) on the external validation dataset, both surpassing existing models. The KFDeep model demonstrates stable performance in simulated dynamic scenarios, with the AUROC progressively increasing over time. Both the calibration curve and decision curve analyses confirm that the model is unbiased and safe for practical use, while the SHAP analysis and hidden layer clustering results align with established medical knowledge. Interpretation: The KFDeep model built from real-world EHRs enhances the prediction accuracy of kidney failure without increasing clinical examination costs and can be easily integrated into existing hospital systems, providing physicians with a continuously updated decision-support tool due to its dynamic design.

Chronic Kidney Disease (CKD) represents a significant global health challenge, characterized by the progressive decline in renal function, leading to the accumulation of waste products and disruptions in fluid balance within the body. Given its pervasive impact on public health, there is a pressing need for effective diagnostic tools to enable timely intervention. Our study delves into the application of cutting-edge transfer learning models for the early detection of CKD. Leveraging a comprehensive and publicly available dataset, we meticulously evaluate the performance of several state-of-the-art models, including EfficientNetV2, InceptionNetV2, MobileNetV2, and the Vision Transformer (ViT) technique. Remarkably, our analysis demonstrates superior accuracy rates, surpassing the 90% threshold with MobileNetV2 and achieving 91.5% accuracy with ViT. Moreover, to enhance predictive capabilities further, we integrate these individual methodologies through ensemble modeling, resulting in our ensemble model exhibiting a remarkable 96% accuracy in the early detection of CKD. This significant advancement holds immense promise for improving clinical outcomes and underscores the critical role of machine learning in addressing complex medical challenges.

Chronic kidney disease (CKD) is a significant public health challenge, often progressing to end-stage renal disease (ESRD) if not detected and managed early. Early intervention, warranted by silent disease progression, can significantly reduce associated morbidity, mortality, and financial burden. In this study, we propose a novel approach to modeling CKD progression using a combination of machine learning techniques and classical statistical models. Building on the work of Liu et al. (2023), we evaluate linear models, tree-based methods, and deep learning models to extract novel predictors for CKD progression, with feature importance assessed using Shapley values. These newly identified predictors, integrated with established clinical features from the Kidney Failure Risk Equation, are then applied within the framework of Cox proportional hazards models to predict CKD progression.